Ayako Fujihara

Ayako Fujihara advises on a wide range of corporate matters, with a particular focus on capital markets transactions and corporate governance issues, as well as M&A transactions.

Ms. Fujihara’s broader corporate practice includes advising on corporate governance matters and periodic and current filings with the SEC, as well as on satisfying requirements set forth by the NYSE and Nasdaq.

Ms. Fujihara’s representations include advising:

• T1 Energy Inc. (f/k/a FREYR Battery, Inc.) on:
  • its $72 million registered direct offering of common stock
  • the $340 million acquisition of the U.S. solar manufacturing assets of Trina Solar Co., Ltd.
  • its redomiciliation from Luxembourg to the U.S.
  • its first SEC-registered follow-on offering of $265 million of ordinary shares
• Tether and Twenty One Capital, Inc. in connection with the launch of Twenty One Capital through a de-SPAC transaction with Cantor Equity Partners, Inc.
• Stena AB on its:
  • high-yield offering of $700 million of senior secured notes due 2031 and $400 million of senior secured notes due 2031
  • $160 million high-yield private placement of the senior secured notes due 2031 in a tap issuance
  • high-yield offering of €325 million of senior secured notes due 2028 and a concurrent tender offer for up to $350 million of Stena’s outstanding senior secured notes due 2024
• Polynt Group on its €1.3 billion multi-tranche high-yield offering of senior secured notes due 2026
• the initial purchasers on a $500 million high-yield offering of senior notes due 2030 by Endeavour Mining plc, as well as a concurrent tender offer for up to $500 million of Endeavour’s outstanding senior notes due 2026
• The Travel Corporation on its acquisition by funds advised by Apollo Global Management, Inc.
• SDCL Edge Acquisition Corporation on its proposed (but terminated) merger with cunova GmbH at an enterprise value of $736 million
• Compute Health Acquisition Corp. on its merger with Allurion Technologies at an enterprise value of $500 million. As a result of the merger, Allurion became a publicly traded company